U.S. markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.49-0.43 (-3.94%)
At close: 4:00PM EDT

10.49 0.00 (0.00%)
After hours: 5:28PM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/29/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
1.83B4.28B1.09B334.49M203.04M
Enterprise Value 3
1.56B4.11B1.10B333.73M183.26M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
477.821.09k178.6250.8826.36
Price/Book (mrq)
9.8223.21316.039.933.79
Enterprise Value/Revenue 3
568.6915.37k825.441.19k211.41
Enterprise Value/EBITDA 6
-7.51-32.92-37.63-9.93-8.68

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 3412.68%
S&P500 52-Week Change 37.69%
52 Week High 333.79
52 Week Low 32.09
50-Day Moving Average 312.73
200-Day Moving Average 315.24

Share Statistics

Avg Vol (3 month) 318.19M
Avg Vol (10 day) 35.99M
Shares Outstanding 5167.52M
Float 164.19M
% Held by Insiders 12.69%
% Held by Institutions 129.41%
Shares Short (Oct 14, 2020) 455.04M
Short Ratio (Oct 14, 2020) 42.19
Short % of Float (Oct 14, 2020) 433.54%
Short % of Shares Outstanding (Oct 14, 2020) 432.85%
Shares Short (prior month Sep 14, 2020) 457.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jun 05, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,045.74%

Management Effectiveness

Return on Assets (ttm)-22.79%
Return on Equity (ttm)-184.48%

Income Statement

Revenue (ttm)2.74M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)96.90%
Gross Profit (ttm)-82.01M
EBITDA -106.74M
Net Income Avi to Common (ttm)-222M
Diluted EPS (ttm)-1.85
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)371.66M
Total Cash Per Share (mrq)2.22
Total Debt (mrq)101.02M
Total Debt/Equity (mrq)54.21
Current Ratio (mrq)10.06
Book Value Per Share (mrq)1.17

Cash Flow Statement

Operating Cash Flow (ttm)-94.08M
Levered Free Cash Flow (ttm)-51.83M